Biofeedback using electrical impedance tomography during inhalation therapy for chronic obstructive lung disease – a pilot study

Technical Summary: Biofeedback Using Electrical Impedance Tomography During Inhalation Therapy for COPD

Problem Statement
Chronic Obstructive Pulmonary Disease (COPD) is characterized by airflow limitation, hyperinflation, and increased respiratory workload, leading to dyspnea and reduced quality of life. While inhalation therapy with bronchodilators and corticosteroids is a cornerstone of treatment, its efficacy is heavily dependent on correct inhalation technique. Incorrect technique often limits drug deposition and treatment success. Although biofeedback training has shown promise in rehabilitation, it remains unclear which visual methods are most effective for identifying and correcting inhalation errors in COPD patients. Electrical Impedance Tomography (EIT) offers real-time, bedside visualization of regional ventilation but has not previously been utilized as a biofeedback tool to optimize inhalation techniques in this patient population.

Methodology
This prospective, randomized, single-blinded pilot study was conducted at the University Hospital of Saarland, Germany. The study enrolled 29 stable COPD patients (15 in the control group, 14 in the intervention group).

• Intervention: Both groups were trained to use a pressurized metered-dose nebulizer with salbutamol. The control group received standard instruction, while the intervention group received visual biofeedback via a real-time EIT monitor (PulmoVista® 500) displaying their thoracic ventilation distribution during the inhalation maneuver.
• Protocol: Participants underwent body plethysmography before and after a single session involving four inhalation cycles of 100 µg salbutamol with a 5–10 second breath hold.
• Measurements:
  • Primary Outcome: Changes in lung function parameters (FEV1, FVC, FRC, TLC, RV, sRtot, sReff) measured via body plethysmography.
  • Secondary Outcomes: Real-time EIT-derived indices (Tidal Impedance Difference [TID], Global Inhomogeneity Index [GI], Regional Ventilation Delay Index [RVDI]) and subjective benefit assessed via a follow-up questionnaire (CAT score and ordinal survey) at approximately 4.8 months.
• Statistical Analysis: Due to non-normal data distribution, the Mann-Whitney test was used for between-group comparisons of pre-post differences.

Key Results

• Lung Function: There were no significant differences between groups regarding obstructive parameters (FEV1, FEV1/FVC) or peak expiratory flow.
• Hyperinflation: The intervention group demonstrated a significant reduction in Functional Residual Capacity (FRC) compared to the control group (median change: -0.4 L vs. -0.1 L; p < 0.05). This corresponds to an 11% predicted reduction in the intervention group versus 2% in the control group.
• Airway Resistance: Contrary to expectations, specific airway resistance (sRtot and sReff) decreased significantly more in the control group than in the intervention group. The authors note this may be due to the complex interplay between lung volume reduction and airway mechanics (radial traction) or breathing pattern changes.
• EIT Parameters: No significant between-group differences were found in EIT-derived indices (TID, GI, RVDI) during inhalation. Notably, the intervention group showed a trend toward increased Regional Ventilation Delay (RVDI), potentially indicating a more conscious, altered breathing pattern.
• Subjective Outcomes: At follow-up, there were no significant differences in CAT scores between groups. However, in the intervention group, 5 out of 12 respondents reported a specific subjective benefit attributed to the EIT biofeedback, whereas no control group participants reported study-derived benefits.

Key Contributions

1. Novel Application: This is the first study to investigate the use of EIT as a real-time biofeedback tool specifically for optimizing inhalation technique in COPD patients.
2. Physiological Insight: The study provides evidence that a single session of EIT-guided biofeedback can acutely reduce hyperinflation (FRC), a parameter the authors suggest may be more sensitive to short-term technique improvements than FEV1.
3. Feasibility: The study demonstrates that COPD patients can understand and utilize real-time EIT ventilation images, with high ratings for the understandability and helpfulness of the visual feedback.

Significance and Claims
The authors conclude that biofeedback using lung EIT may improve inhalation technique and medication deposition, resulting in decreased hyperinflation. They posit that the observed reduction in FRC is a clinically relevant indicator of improved breathing mechanics, potentially mediated by better exhalation control or more effective drug delivery.

However, the paper maintains a modest tone regarding its broader implications:

• The lack of change in FEV1 and EIT-derived ventilation distribution indices suggests that the physiological effects are complex and not solely driven by immediate changes in regional ventilation homogeneity.
• The authors acknowledge that a single intervention session may be insufficient to induce sustained changes in breathing behavior or subjective disease burden (CAT scores).
• They suggest that future research should focus on repeated training sessions to consolidate technique and investigate whether specific patient subgroups (e.g., those with pronounced hyperinflation) derive greater benefit.
• The study highlights the need for larger cohorts to improve statistical power, particularly for EIT-derived parameters, which were limited by data artifacts in this pilot.

Ultimately, the paper claims that while EIT biofeedback shows promise for reducing hyperinflation in a single session, its role as a standard therapeutic tool requires further validation through longitudinal studies.